Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
CNOOC
00883
5
YANCHANG PETRO
00346
CN Stock MarketDetailed Quotes
Zhejiang Hisoar Pharmaceutical (002099)
- 7.16
- +0.08+1.13%
Market Closed Apr 17 15:00 CST
11.59BMarket Cap-34.59P/E (TTM)
7.37High7.01Low303.97KlotVolume7.07Open7.08Prev Close219.82MTurnover1.88%Turnover RatioLossP/E (Static)1.62BShares9.0952wk High2.26P/B11.57BFloat Cap4.7852wk Low7.79Limit Up1.62BShs Float17.62Historical High6.37Limit Down5.09%Range %-0.28Historical Low--Dividend TTM7.23Avg Price141.04KlotAsk--Div Yield TTM100Lot Size158.14KlotBid
Zhejiang Hisoar Pharmaceutical (002099) Income Statement
All
YOY
| (Q9)Sep 30, 2025 | (Q6)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total operating revenue | -5.39%1.37B | -10.94%925.16M | -7.95%486.43M | -10.75%1.94B | -13.85%1.44B | -13.17%1.04B | -16.65%528.46M | -19.68%2.17B | -19.05%1.68B | -18.49%1.2B |
| Operating revenue | -5.39%1.37B | -10.94%925.16M | -7.95%486.43M | -10.75%1.94B | -13.85%1.44B | -13.17%1.04B | -16.65%528.46M | -19.68%2.17B | -19.05%1.68B | -18.49%1.2B |
| Other operating revenue | ---- | -36.24%7.33M | ---- | 79.83%16.43M | ---- | 40.48%11.49M | ---- | 43.04%9.14M | ---- | 400.64%8.18M |
| Total operating cost | -2.84%1.34B | -7.22%892.85M | 3.12%466.68M | -20.32%1.86B | -17.08%1.38B | -15.07%962.35M | -29.52%452.55M | -5.77%2.33B | -7.61%1.66B | -10.89%1.13B |
| Operating cost | -3.62%1.01B | -8.46%683.42M | 0.57%364.12M | -23.94%1.42B | -22.36%1.05B | -21.75%746.61M | -28.59%362.06M | -5.88%1.87B | -7.55%1.35B | -6.35%954.19M |
| Operating tax surcharges | 21.66%23.89M | 32.06%16.85M | 41.71%8.88M | 4.45%28.99M | -4.01%19.64M | -6.08%12.76M | 3.37%6.27M | 30.47%27.76M | 32.83%20.46M | 28.97%13.59M |
| Operating expense | -27.91%16.3M | -31.53%9.63M | -48.58%2.71M | 13.81%33.25M | 7.77%22.61M | 4.43%14.07M | 10.46%5.27M | 11.18%29.22M | 19.54%20.98M | 20.21%13.47M |
| Administration expense | -3.28%204.66M | -7.49%133.33M | 10.48%69.26M | -5.36%307.46M | -6.86%211.6M | -0.47%144.13M | -8.14%62.69M | -19.27%324.87M | -31.65%227.19M | -33.38%144.81M |
| Financial expense | 62.80%-9.48M | 38.89%-11.88M | 34.95%-8.94M | -91.79%-60.07M | 53.46%-25.48M | 65.34%-19.44M | -155.09%-13.75M | 69.44%-31.32M | 61.24%-54.75M | 4.34%-56.08M |
| -Interest expense (Financial expense) | -10.37%20.59M | -19.60%15.04M | -28.01%8.04M | -23.74%28.8M | -14.76%22.98M | 4.99%18.71M | 88.17%11.17M | 3.33%37.76M | 10.81%26.95M | 2.20%17.82M |
| -Interest Income (Financial expense) | 11.38%-39.46M | 0.05%-25.54M | 38.82%-12.03M | 18.02%-55.85M | 23.08%-44.52M | 38.60%-25.55M | -105.94%-19.66M | -103.54%-68.13M | -195.84%-57.88M | -161.12%-41.61M |
| Research and development | -8.29%89.6M | -4.24%61.5M | 2.14%30.65M | 12.01%129.45M | 4.74%97.7M | 1.80%64.22M | -3.32%30.01M | -20.25%115.56M | -14.55%93.28M | -12.49%63.09M |
| Credit Impairment Loss | -170.02%-2.25M | 48.83%-1.32M | -714.78%-2.5M | -133.88%-4.54M | -84.03%3.21M | -120.22%-2.57M | -96.35%407.05K | 176.54%13.41M | 958.83%20.13M | 333.38%12.73M |
| Asset Impairment Loss | 69.61%-28.44M | 57.03%-21.39M | 75.72%-11.57M | -78.75%-425.17M | ---93.57M | ---49.77M | ---47.65M | -183.95%-237.86M | ---- | ---- |
| Other net revenue | 91.25%-5.87M | 81.77%-7.53M | 91.99%-3.76M | -37.18%-415.37M | -8.37%-67.05M | 9.22%-41.28M | -189.56%-46.91M | -155.65%-302.79M | -57.14%-61.87M | -4,707.11%-45.48M |
| Fair value change income | -215.19%-387.13K | 2.14%6.9M | --3.05M | 84.18%-16.49M | 100.77%336.07K | 110.54%6.76M | ---- | -432.34%-104.25M | 9.15%-43.8M | -1,365.09%-64.16M |
| Invest income | 50.81%10.19M | 55.08%-3.17M | 130.64%1.85M | 165.69%8.78M | 111.00%6.76M | 42.43%-7.06M | -129.99%-6.03M | 41.24%-13.37M | -1,670.11%-61.42M | -800.04%-12.26M |
| -Including: Investment income associates | 45.69%-3.76M | 52.16%-2.46M | 71.15%-1.12M | 33.59%-11.19M | 20.94%-6.93M | 42.47%-5.14M | -27.25%-3.87M | 48.91%-16.84M | 10.99%-8.77M | -30.22%-8.93M |
| Asset deal income | -102.36%-12.91K | -107.14%-26.08K | -142.32%-98.06K | -91.95%1.04M | -94.43%547.93K | -96.53%365.09K | -97.21%231.69K | 4,326.85%12.88M | 1,926.27%9.84M | 2,950.15%10.53M |
| Other revenue | -4.10%15.03M | 4.31%11.47M | -9.96%5.52M | -20.43%21.01M | 17.14%15.67M | 43.20%10.99M | 71.87%6.13M | 6.06%26.41M | -5.54%13.38M | -12.01%7.68M |
| Operating profit | 1,307.03%24.14M | -29.61%24.78M | -44.85%16M | 27.59%-336.14M | 103.87%1.72M | 96.70%35.21M | -34.52%29.01M | -524.36%-464.24M | -118.80%-44.36M | -90.93%17.9M |
| Add:Non operating Income | 85.26%3.79M | 27.05%2.01M | -30.73%704.11K | 1,027.74%2.75M | 6,028.47%2.05M | 2,933.32%1.58M | 6,373.93%1.02M | -84.09%243.96K | -96.48%33.4K | -94.95%52.14K |
| Less:Non operating expense | 1,282.91%9.35M | 2,509.10%7.49M | 1,992.86%4.1M | 56.86%3.49M | -51.85%675.88K | -68.19%287.25K | -19.98%196.06K | -78.04%2.22M | 32.87%1.4M | 1,322.93%902.99K |
| Total profit | 502.05%18.58M | -47.14%19.3M | -57.76%12.6M | 27.74%-336.88M | 106.75%3.09M | 114.11%36.5M | -32.32%29.83M | -562.51%-466.22M | -119.38%-45.73M | -91.40%17.05M |
| Less:Income tax cost | 289.53%13.55M | 3,147.35%6.67M | 288.86%4.29M | 93.29%-2.99M | -14.38%-7.15M | 84.27%-218.95K | -202.14%-2.27M | -403.17%-44.64M | -120.84%-6.25M | -105.06%-1.39M |
| Net profit | -50.78%5.04M | -65.62%12.62M | -74.10%8.31M | 20.80%-333.89M | 125.92%10.23M | 99.14%36.72M | -23.30%32.1M | -589.77%-421.58M | -119.17%-39.48M | -89.20%18.44M |
| Net profit from continuing operation | -50.78%5.04M | -65.62%12.62M | -74.10%8.31M | 20.80%-333.89M | 125.92%10.23M | 99.14%36.72M | -23.30%32.1M | -589.77%-421.58M | -119.17%-39.48M | -89.20%18.44M |
| Less:Minority Profit | -29.09%-2.25M | -6.27%-1.47M | -84.95%-916.51K | -137.36%-3.62M | -95.83%-1.75M | -88.73%-1.38M | -95.86%-495.53K | 21.20%-1.53M | 25.34%-891.29K | 14.95%-733.19K |
| Net profit of parent company owners | -39.15%7.29M | -63.01%14.09M | -71.68%9.23M | 21.38%-330.27M | 131.05%11.98M | 98.74%38.1M | -22.58%32.59M | -577.26%-420.06M | -118.63%-38.59M | -88.83%19.17M |
| Earning per share | ||||||||||
| Basic earning per share | --0 | -50.00%0.01 | -50.00%0.01 | 19.23%-0.21 | 150.00%0.01 | 100.00%0.02 | 0.00%0.02 | -620.00%-0.26 | -115.38%-0.02 | -90.91%0.01 |
| Diluted earning per share | --0 | -50.00%0.01 | -50.00%0.01 | 19.23%-0.21 | 150.00%0.01 | 100.00%0.02 | 0.00%0.02 | -620.00%-0.26 | -115.38%-0.02 | -90.91%0.01 |
| Other composite income | 703.25%3.83M | -115.03%-634.72K | ||||||||
| Other composite income of parent company owners | ---- | ---- | ---- | 703.25%3.83M | ---- | ---- | ---- | -115.03%-634.72K | ---- | ---- |
| Total composite income | -50.78%5.04M | -65.62%12.62M | -74.10%8.31M | 21.83%-330.06M | 125.92%10.23M | 99.14%36.72M | -23.30%32.1M | -567.56%-422.22M | -119.20%-39.48M | -89.20%18.44M |
| Total composite income of parent company owners | -39.15%7.29M | -63.01%14.09M | -71.68%9.23M | 22.40%-326.44M | 131.05%11.98M | 98.74%38.1M | -22.58%32.59M | -556.10%-420.69M | -118.66%-38.59M | -88.83%19.17M |
| Total composite income of minority owners | -29.09%-2.25M | -6.27%-1.47M | -84.95%-916.51K | -137.36%-3.62M | -95.83%-1.75M | -88.73%-1.38M | -95.86%-495.53K | 21.20%-1.53M | 25.34%-891.29K | 14.95%-733.19K |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | Tianjian Certified Public Accountants (Special General Partnership) | -- | -- | -- | Tianjian Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Market Insights
Hot Topics Hot Topics
Middle East conflict spreads to the stock market! How should investors respond?
Lebanon and Israel will implement a 10-day ceasefire! On the 16th, US President Trump stated that the next round of talks between the US and
牛牛課堂
Mar 4 17:09
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
牛牛課堂
Mar 18 18:18
Hormuz, Term Structure and USO: Navigating the Energy Storm